By Chadi Nabhan, MD, MBA, FACP - Last Updated: January 26, 2023
Sanam Loghavi, MD, stops by The HemOnc Pulse and chats with host Chadi Nabhan, MD, MBA, FACP, about why she thinks 2022 was a major year for MDS in this latest episode of the podcast. With the unveiling of the two new MDS classification systems in the past year, Dr. Loghavi breaks down the classification models and what it means for the specialty.
Listen to the episode HERE.
Original Source: Sanam Loghavi, MD, Tells Us Why 2022 was a Major Year for MDS | Blood Cancers Today